Quantcast Acelity - ABTHERA™ Open Abdomen Negative Pressure Therapy System
MENU

ABTHERA™ Open Abdomen Negative Pressure Therapy System


ABTHERA™ Therapy System
ABTHERA™ Therapy System
ABTHERA™ Open Abdomen Dressing
ABTHERA™ Open Abdomen Dressing

A Temporary Abdominal Closure (TAC) System that Allows Surgeons to Take Control Early in Managing a Challenging Open Abdomen, Helping to Achieve Primary Fascial Closure

The ABTHERA™ Therapy System is designed to
 
  • Remove peritoneal fluid, helping to reduce edema
  • Provide medial tension which helps minimize fascial retraction and loss of domain1
  • Provide separation between the abdominal wall and viscera, protecting abdominal contents
  • Allow rapid access for re-entry and does not require sutures for placement
 

Overview

Uniquely designed to actively manage the open abdomen

Multiple clinical studies have shown improved primary fascial closure rates compared to Barker’s Vacuum Packing Technique
 

ABTHERA™ Therapy can also be delivered via the negative pressure provided by V.A.C.ULTA™, INFOV.A.C.™ and V.A.C. ATS™ Therapy Units.
 

How it Works

  • About
  • Specifications
  • Materials For Download

About

Designed for simplicity, ease-of-use and rapid application

Provides continuous negative pressure to remove high-volume exudate.
  • ABTHERA™ Drape: Provides a closed system to help isolate and protect abdominal contents from external environment
 
  • ABTHERA™ Perforated Foam: Negative pressure delivered through the foam provides medial tension, which helps minimize fascial retraction and loss of domain1
 
  • ABTHERA™ Visceral Protective Layer:
 
  • Enhances fluid removal from paracolic gutters
  • No sutures required for placement, minimizing fascial damage
  • Provides separation between abdominal wall and viscera, protecting abdominal contents
 
ABTHERA™ Therapy for the management of the open abdomen
 
The ABTHERA™ Therapy System is designed to
 
  • Remove peritoneal fluid, helping to reduce edema
  • Provide medial tension which helps minimize fascial retraction and loss of domain
  • Provide separation between the abdominal wall and viscera, protecting abdominal contents
  • Allow rapid access for re-entry and does not require sutures for placement
 

Specifications

ABTHERA™ Therapy Unit
Dimensions :                                  11.0”H x 11.25”L x 6.0”D (27.94cm x 28.6cm x 5.2cm) 
Weight (Therapy Unit only) :        5.7lbs/2.6kg
Canister Volume :                          1,000cc/ml
Electrical : Power Supply Input:   100V~ -240V~ 50/60Hz
Power Supply Current :                 2.5A max (100V)0.9A (100V~), 0.4A(240V~)
Current Leakage :                          <100 Microamps
Battery run life :                            ~2 hours
Battery charge time :                    ~8 hours
 
Storage Conditions
Temperature Range                       -20°F(-29°C) to 140°F(60°C)
 
Operating Conditions
Temperature Range:                       50°F(10°C) to 100°F(38°C)
Altitude Range Optimum
Performance:                                   0 to 8, 000ft (0 to 2438m)
 
ABTHERA™ Visceral Protective Layer
Dimensions :                                   665mm x 802mm
Encapsulated Foam Thickness :    10mm
Polyurethane Layer Thickness :    160 microns
Shelf Life 3 years at room temperature
Sterile, made without natural rubber latex
 

Indications & Applications

Indications & Applications

  • Indications
  • Applications

Indications for Use

Instructions for Use:

Before use, physicians should review complete risk information and essential prescribing information which can be found in the Product Instructions for Use .
 
  • Temporary bridging of abdominal wall openings where primary closure is not possible and/or repeat abdominal entries are necessary
  • Intended use of the system is for use in open abdominal wounds, with exposed viscera, including, but not limited to, abdominal compartment syndrome
  • Intended care setting is a closely monitored area within the acute care hospital, such as the ICU. The abdominal dressing will most often be applied in the operating theater
 

Applications

Evidence & Outcomes

ABTHERA™ Therapy has been shown in clinical studies to be associated with positive clinical outcomes. Some of them are listed below.

Clinical Evidence

Additional summary of evidence and outcomes.

Evidence & Outcomes

Product Evidence and Outcomes

Title Study Type Date Authors